Skip to main content

Table 1 Baseline characteristics of the patients

From: The association between prothrombin time-international normalized ratio and long-term mortality in patients with coronary artery disease: a large cohort retrospective study with 44,662 patients

Characteristic

PT-INR level quartile

Overall

 ≤ 0.96

0.96–1.01

1.01–1.06

 > 1.06

p Value

(n = 44,662)

(n = 12,014)

(n = 12,389)

(n = 9936)

(n = 10,323)

Demographic

Age, year

62.96 (10.71)

60.98 (10.15)

62.31 (10.54)

63.75 (10.72)

65.28 (11.01)

 < 0.001

Male, n (%)

33,938 (75.99)

8583 (71.44)

9353 (75.49)

7688 (77.38)

8314 (80.54)

 < 0.001

Medical history

AMI, n (%)

8544 (19.15)

1447 (12.06)

1931 (15.60)

1973 (19.88)

3193 (30.98)

 < 0.001

CHF, n (%)

3830 (8.58)

601 (5.01)

761 (6.15)

820 (8.26)

1648 (15.98)

 < 0.001

Hypertension, n (%)

25,415 (56.98)

6920 (57.68)

7021 (56.74)

5732 (57.76)

5742 (55.70)

0.007

DM, n (%)

12,423 (27.85)

3582 (29.85)

3384 (27.35)

2564 (25.84)

2893 (28.07)

 < 0.001

PCI, n (%)

33,284 (74.52)

8746 (72.80)

9142 (73.79)

7464 (75.12)

7932 (76.84)

 < 0.001

CKD, n (%)

7833 (21.56)

1479 (15.49)

1803 (18.18)

1764 (21.77)

2787 (31.79)

 < 0.001

Laboratory test

INR

1.02 (0.13)

0.93 (0.03)

0.99 (0.01)

1.04 (0.01)

1.15 (0.20)

 < 0.001

D-dimer (ng/mL)

624.48 (1256.03)

474.66 (810.95)

514.92 (863.34)

605.73 (1116.67)

949.80 (1956.06)

 < 0.001

FIB, g/L

4.12 (1.28)

4.03 (1.04)

4.07 (1.18)

4.14 (1.31)

4.26 (1.59)

 < 0.001

ALT (U/L)

34.36 (84.89)

31.91 (28.61)

30.99 (54.32)

30.65 (31.11)

44.78 (159.84)

 < 0.001

AST (U/L)

48.92 (196.68)

33.70 (44.46)

36.43 (55.56)

42.20 (70.42)

88.06 (393.12)

 < 0.001

WBC, 109/L

7.97 (2.71)

7.73 (2.14)

7.73 (2.31)

7.84 (2.60)

8.67 (3.59)

 < 0.001

HGB, g/L

133.13 (16.75)

136.64 (14.81)

134.83 (15.58)

132.29 (16.44)

127.82 (18.98)

 < 0.001

CHOL, mmol/L

4.54 (1.21)

4.87 (1.27)

4.59 (1.18)

4.41 (1.13)

4.21 (1.14)

 < 0.001

TRIG, mmol/L

1.67 (1.22)

2.05 (1.68)

1.69 (1.11)

1.53 (0.93)

1.34 (0.76)

 < 0.001

LDLC, mmol/L

2.80 (0.97)

2.97 (1.01)

2.84 (0.97)

2.73 (0.93)

2.63 (0.94)

 < 0.001

HDLC, mmol/L

1.00 (0.26)

1.04 (0.27)

1.00 (0.25)

0.98 (0.25)

0.95 (0.25)

 < 0.001

HbA1c, %

6.56 (1.42)

6.69 (1.52)

6.53 (1.38)

6.51 (1.39)

6.50 (1.37)

 < 0.001

URIC, μmol/L

393.52 (110.49)

393.45 (102.21)

389.57 (102.89)

390.74 (109.23)

401.10 (128.07)

 < 0.001

eGFR, ml/min/1.73 m2

77.95 (25.22)

82.87 (25.19)

79.64 (23.69)

77.33 (24.39)

71.25 (26.18)

 < 0.001

ALB, g/L

36.37 (4.22)

37.40 (3.79)

36.93 (3.88)

36.31 (4.03)

34.55 (4.65)

 < 0.001

Hs-CRP, mg/L

12.07(22.75)

6.24 (11.82)

8.66 (18.00)

11.60 (23.36)

23.40 (40.60)

 < 0.001

Medication

Antiplatelet, n (%)

42,965 (97.41)

11,606 (97.34)

11,945 (97.24)

9596 (97.59)

9818 (97.54)

0.318

ACEI/ARB, n (%)

22,110 (50.13)

5801 (48.65)

6130 (49.90)

4942 (50.26)

5237 (52.03)

 < 0.001

Beta-blockers, n (%)

35,957 (81.52)

9804 (82.23)

10,039 (81.72)

8008 (81.44)

8106 (80.53)

0.012

Statin, n (%)

42,274 (95.85)

11,488 (96.35)

11,812 (96.16)

9434 (95.94)

9540 (94.77)

 < 0.001

Death, n (%)

5613 (12.57)

1116 (9.29)

1426 (11.51)

1249 (12.57)

1822 (17.65)

 < 0.001

  1. AMI acute myocardial infarction, CHF congestive heart failure, DM diabetes mellitus, PCI percutaneous coronary intervention, CKD chronic kidney disease, WBC white blood cell, HGB hemoglobin, CHOL serum total cholesterol, LDL-C low-density lipoprotein cholesterol, HDL-C hight-density lipoprotein cholesterol, HbA1c Glycated hemoglobin, eGFR estimated glomerular filtration rate, ALB albumin, Hs-CRP hypersensitive C-reactive protein, ACEI/ARB angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, AST aspartate transaminase, ALT alanine aminotransferase, FIB fibrinogen